Skip to main content Accessibility help
×
×
Home
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 1
  • Cited by
    This chapter has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Hamilton, Ian 2017. Cannabis, psychosis and schizophrenia: unravelling a complex interaction. Addiction, Vol. 112, Issue. 9, p. 1653.

    ×
  • Print publication year: 2011
  • Online publication date: November 2011

20 - Understanding cannabis use in schizophrenia

Summary

The cerebellar peduncles are large axon bundles that interconnect the cerebellum with other areas of the nervous system. It is now well established that the cerebellum contains one of the highest densities of CB1 receptors in the mammalian brain. It appears that the primary mode of action of endocannabinoids in the cerebellum is self-regulation by Purkinje cells via retrograde signaling back to the presynaptic terminals that innervate them. In terms of behavioral outcomes, several studies have shown that cannabinoid administration in humans is associated with alterations in temporal processing and psychomotor performance, both of which are at least partly cerebellar-mediated. In addition to alterations in cerebellar-mediated behavioral outcomes, numerous studies have shown that patients with schizophrenia exhibit abnormalities in cerebellar structure and metabolism. To recapitulate, the current chapter has attempted to synthesize known literatures regarding the effect of cannabinoids on cerebellar function and the role of the cerebellum in schizophrenia.
Recommend this book

Email your librarian or administrator to recommend adding this book to your organisation's collection.

Marijuana and Madness
  • Online ISBN: 9780511706080
  • Book DOI: https://doi.org/10.1017/CBO9780511706080
Please enter your name
Please enter a valid email address
Who would you like to send this to *
×

References

Addington, J. and Duchak, V. (1997) Reasons for substance use in schizophrenia. Acta Psychiatr Scand, 96:329–33.
Ames, S.L., Grenard, J.L., Thush, C., Sussman, S., Wiers, R.W. and Stacey, A.W. (2007) Comparison of indirect assessments of association as predictors of marijuana use among at-risk adolescents. Exp Clin Psychopharmacol, 15:204–18.
Anthony, J.C. and Helzer, J.E. (1991) Syndromes of drug abuse and dependence. In: Robins, L. N. and Regir, D. A. (eds.) Psychiatric Disorders in America: The Epidemiologic Catchment Area StudyNew York: Free Press.
Arseneault, L., Cannon, M., Poulton, R., Murray, R., Avshalam, C. and Moffitt, T.E. (2002) Cannabis use in adolescence and risk for adult psychosis: Longitudinal prospective study. BMJ, 325:1195–9.
Baigent, M., Holme, G. and Hafner, R.J. (1995) Self reports of the interaction between substance abuse and schizophrenia. Aust NZ J Psychiatry, 29:69–74.
Barkus, E. and Lewis, S. (2008) Schizotypy and psychosis-like experiences from recreational cannabis in a non-clinical sample. Psychological Medicine, 38:1267–76.
Barkus, E., Stirling, J., Hopkins, R. and Lewis, S. (2006) Cannabis-induced psychosis-like experiences are associated with high schizotypy. Psychopathology, 39:175–8.
Blanchard, J.J., Brown, S.A., Horan, W.P. and Sherwood, A.R. (2000a) Substance use disorders in schizophrenia: Review, integration and a proposed model. Clin Psychol Rev, 20:207–34.
Blanchard, J.J., Brown, S.A., Horan, W.P. and Sherwood, A.R. (2000b) Substance use disorders in schizophrenia: Review, integration, and a proposed model. Clin Psychol Rev, 20:207–34.
Blanchard, J.J., Mueser, K.T. and Bellack, A.S. (1998) Anhedonia, positive and negative affect, and social functioning in schizophrenia. Schizophr Bull, 24:413–24.
Caspi, A., Moffitt, T.E., Cannon, M., et al. (2005) Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene x environment interaction. Biol Psychiatry, 57:1117–27.
Cohen, M., Solowij, N. and Carr, V. (2008) Cannabis, cannabinoids and schizophrenia: integration of the evidence. Aust NZ J Psychiatry, 42:357–68.
Coulston, C.M., Perdices, M. and Tennant, C.C. (2007) The neuropsychology of cannabis and other substance use in schizophrenia: Review of the literature and critical evaluation of methodological issues. Aust NZ J Psychiatry, 41:869–84.
Degenhardt, L., Hall, W. and Lynskey, M. (2001) Alcohol, cannabis and tobacco use among Australians: A comparison of their associations with other drug use and use disorders, affective and anxiety disorders, and psychosis. Addiction, 96:1603–14.
Degenhardt, L., Tennant, C., Gilmour, S., et al. (2007) The temporal dynamics of relationships between cannabis, psychosis and depression among young adults with psychotic disorders: findings from a 10-month prospective study. Psychol Med, 37:927–34.
Dixon, L., Haas, G., Weiden, P.J., Sweeney, J. and Frances, A.J. (1991) Drug abuse in schizophrenic patients: Clinical correlates and reasons for use. Am J Psychiatry, 148:224–30.
Dixon, L., Haas, G.H., Dulit, R.A., Weiden, P.J., Sweeney, J. and Hien, D. (1989) Substance use in schizophrenia: Preferences, predictors and psychopathology. Schizophr Res, 2:6.
Farrell, M., Howes, S., Bebbington, P., et al. (2001) Nicotine, alcohol and drug dependence and psychiatric comorbidity: Results of a national household survey. Brit J Psychiatry, 179:432–7.
Ferdinand, R.F., Sondeijker, F., Van Der Ende, J., Selten, J.P., Huizink, A. and Verhulst, F.C. (2005) Cannabis use predicts future psychotic symptoms, and vice versa. Addiction, 100:612–17.
Fergusson, D.M., Horwood, L.J. and Swain-Campbell, N.R. (2003) Cannabis dependence and psychotic symptoms in young people. Psychol Med, 33:15–21.
Fowler, I.L., Carr, V.J., Carter, N.T. and Lewin, T.J. (1998) Patterns of current and lifetime substance use in schizophrenia. Schizophr Bull, 24:443–55.
Gleeson, J.F., Rawlings, D., Jackson, H.J., et al. (2005) Agreeableness and neuroticism as predictors of relapse after first-episode psychosis: A prospective follow-up study. Journal of Nervous and Mental Disease, 193:160–169.
Green, B., Kavanagh, D. and Young, R. (2003) Being stoned: A review of self-reported cannabis effects. Drug Alcohol Rev, 22:453–60.
Green, B., Kavanagh, D.J. and Young, R.M. (2007) Predictors of cannabis use in men with and without psychosis. Addict Behav, 32:2879–87.
Gregg, L., Barrowclough, C. and Haddock, G. (2007) Reasons for increased substance use in psychosis. Clin Psychol Rev, 27:494–510.
Henquet, C., Van Os, J., Kuepper, R., et al. (2010) Psychosis reactivity to cannabis use in daily life: An experience sampling study. Brit J Psychiatry, 196:447–53.
Hettema, J.M., Prescott, C.A. and Kendler, K.S. (2004) Genetic and environmental sources of covariation between generalized anxiety disorder and neuroticism. Am J Psychiatry, 161:1581–7.
Hides, L., Dawe, S., Kavanagh, D.J. and Young, R.M. (2006) Psychotic symptom and cannabis relapse in recent onset psychosis: Prospective study. Brit J Psychiatry, 189:137–43.
Hides, L., Kavanagh, D.J., Dawe, S. and Young, R.M. (2009) The influence of cannabis use expectancies on cannabis use and psychotic symptoms in psychosis. Drug Alcohol Rev, 28:250–6.
Hodgins, S., Toupin, J. and Côté, G. (1996) Schizophrenia and antisocial personality disorder: A criminal combination. In: Schlesinger, L. B. (ed.) Explorations in Criminal Psychopathology: Clinical Syndromes with Forensic Implications. Springfield, IL: Charles C. Thomas.
Jang, K.L., Hu, S., Livesley, W.J., et al. (2001) Covariance structure of neuroticism and agreeableness: A twin and molecular genetic analysis of the role of the serotonin transporter gene. J Pers Soc Psychol, 81:295–304.
Kelly, A.B., Masterman, P.W. and Marlatt, G.A. (2005) Alcohol related associative strength and drinking behaviors: concurrent and prospective relationships. Drug Alcohol Rev, 24:489–98.
Kelly, A.B., Masterman, P.W. and Young, R.M. (2011) Negative mood, implicit alcohol-related memory, and alcohol use in young adults: The moderating effect of alcohol expectancy. Addictive Behaviors, 36:148–157.
Khantzian, E.J. (1997) The self-medication hypothesis of substance use disorders: A reconsideration and recent applications. Harv Rev Psychiatry, 4:231–44.
Kuntsche, E., Von Fischer, M. and Gerhard, G. (2008) Personality factors and alcohol use: A mediator analysis of drinking motives. Pers Individ Dif, 45:796–800.
Kwapil, T.R. (1996) A longitudinal study of drug and alcohol use by psychosis-prone and impulsive-nonconforming individuals. J Abnorm Psychol, 105:114–23.
Lenzenweger, M.F. (2010) Schizotypy and Schizophrenia: The View from Experimental Psychopathology, New York, Guilford Press.
Lobbana, F., Barrowclough, C., Jeffery, S., et al. (2010) Understanding factors influencing substance use in people with recent onset psychosis: A qualitative study. Soc Sci Med, 70:1141–7.
Mason, O., Morgan, C., Dhiman, S., et al. (2009) Acute cannabis use causes increased psychotomimetic experiences in individuals prone to psychosis. Psychol Med, 39:951–6.
Merikangas, K.R., Mehta, R.L., Molnar, B.E., et al. (1998) Comorbidity of substance use disorders with mood and anxiety disorders: Results of the international consortium in psychiatric epidemiology. Addict Behav, 23:893–908.
Mezquita, L., Stewart, S.H. and Ruipérez, M. (2010) Big-five personality domains predict internal drinking motives in young adults. Personality and Individual Differences, 49:240–5.
Moore, T. H., Zammit, S., Lingford-Hughes, A., et al. (2007) Cannabis use and risk of psychotic or affective mental health outcomes: A systematic review. Lancet, 370:319–28.
Mueser, K.T., Drake, R.E. and Wallach, M.A. (1998) Dual diagnosis: A review of etiological theories. Addict Behav, 23:717–34.
Mueser, K.T., Nishith, P., Tracy, J.I., Degirolamo, J. and Molinaro, M. (1995) Expectations and motives for substance use in schizophrenia. Schizophr Bull, 21:367–78.
Mueser, K.T., Yarnold, P.R., Rosenberg, S.D., Swett, C., Miles, K.M. and Hill, D. (2000) Substance use disorder in hospitalized severely mentally ill psychiatric patients: prevalence, correlates, and subgroups. Schizophr Bull, 26:179–92.
Pallanti, S., Quercioli, L. and Pazzagli, A. (1997) Relapse in young paranoid schizophrenic patients: A prospective study of stressful life events, P300 measures, and coping. Am J Psychiatry, 154:792–8.
Robins, L.N. (1966) Deviant Children Grown Up, Huntington, NY, Robert E. Krieger Publishing Company.
Rooke, S.E., Hine, D.W. and Thorsteinsson, E.B. (2008) Implicit cognition and substance use: A meta-analysis. Addict Behav, 33:1314–28.
Schofield, D., Tennant, C.C., Nash, L., et al. (2006) Reasons for cannabis use in psychosis. Aust NZ J Psychiatry, 40:570–4.
Sinha, R. (2001) How does stress increase risk of drug abuse and relapse?Psychopharmacology, 158:343–59.
Spencer, C., Castle, D. and Michie, P.T. (2002) Motivations that maintain substance use among individuals with psychotic disorders. Schizophr Bull, 28:233–47.
Stacy, A.W. and Wiers, R.W. (2010) Implicit cognition and addiction: A tool for explaining paradoxical behavior. Ann Rev Clin Psychol, 6:551–75.
Stirling, J., Barkus, E., Nabosi, L., Irshad, S., Roemer, G. and Schreudergoidheijt, B. (2008) Cannabis-induced psychotic-like experiences are predicted by high schizotypy: Confirmation of preliminary results in a large cohort. Psychopathology, 41:371–8.
Test, M.A., Wallisch, L.S., Allness, D.J. and Ripp, K. (1989) Substance use in young adults with schizophrenic disorders. Schizophr Bull, 15:465–76.
Thornicroft, G. (1990) Cannabis and psychosis: Is there epidemiological evidence for an association?Brit J Psychiatry, 157:25–33.
van Winkel, R., Henquet, C., Rosa, A., et al. (2008) Evidence that the COMTVal158Met polymorphism moderates sensitivity to stress in psychosis: an experience-sampling study. Am J Med Genet B (Neuropsychiatr Gen), 147B:10–17.
Ventura, J., Nuechterlein, K.H., Hardesty, J.P. and Gitlin, M. (1992) Life events and schizophrenic relapse after withdrawal from medication. Brit J Psychiatry, 161:615–20.
Verdoux, H., Gindre, C., Sorbora, F., Tournier, M. and Swendsen, J.D. (2003) Effects of cannabis and psychosis vulnerability in daily life: An experience sampling test study. Psychol Med, 33:23–32.
Warner, R., Taylor, D., Wright, J., et al. (1994) Substance use among the mentally ill: Prevalence, reasons for use, and effects on illness. Am J Orthopsychiatry, 64:30–9.
Wiers, R.W., Stacy, A.W., Ames, S.L., et al. (2002) Implicit and explicit alcohol-related cognitions. Alcoholism Clin Exp Res, 26:129–37.
Wills, T.A., Sandy, J.M., Shinar, O. and Yaeger, A. (1999) Contributions of positive and negative affect to adolescent substance use: Test of a bidimensional model in a longitudinal study. Psychol Addict Behav, 13:327–38.
Zammit, S., Moore, T.H., Lingford-Hughes, A., et al. (2008) Effects of cannabis use on outcomes of psychotic disorders: systematic review. Brit J Psychiatry, 193:357–63.
Zammit, S., Spurlock, G., Williams, H., et al. (2007) Genotype effects of CHRNA7, CNRI and COMT in schizophrenia: interactions with tobacco and cannabis use. Brit J Psychiatry, 191:402–7.